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Abstract
Background: Propofol infusion syndrome （PRIS） is characterized by lactic acidosis, rhabdomyolysis, 
and circulatory collapse after several days of high-dose propofol infusion. PRIS typically affects young and 
critically ill patients and is a potentially fatal cardiovascular and metabolic condition. On the contrary, 
short period intravenous drip and intermittent intravenous administration of propofol are commonplace 
in the operating theatre, however, there are no biochemical data indicating the safety of these settings in 
Japanese children.
Methods: Thirty consecutive children who were admitted to the pediatric intensive care unit （PICU） 
after elective neurosurgical surgery and anesthetized by propofol infusion were enrolled. The total dosage 
and average speed of propofol infusion during the operation was calculated. The serum lactate level, blood 
gas analysis including the pH, bicarbonate, base excess, and electrolytes were assessed postoperatively.
Results: The total dosage of propofol administered during surgery was 53.8 （37.4-71.1） mg/kg. 
The average speed of Propofol infusion administered during surgery was 9.9 （8.6-11.9） mg/kg/hr. No 
case of PRIS or mortality occurred among these patients. All the patients had normal serum lactate and 
potassium levels. The blood gas pH was normal in most samples, but the bicarbonate and base excess were 
slightly low. However, there was no statistically significant difference in the total dose or average speed of 
propofol administration except for the lower bicarbonate level related to the higher average infusion speed 
of propofol.
Conclusion: Our observational study revealed that the maximum mean rate of 9.9 mg/kg/hr and a 
total dosage of 53.8 mg/kg did not induce PRIS or death, did not elevate the serum lactate or potassium 
level, and slightly decreased the blood gas pH. The base excess was unaffected by the propofol dosage/
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Ⅰ．Introduction
 The propofol infusion syndrome （PRIS） is a 
potentially fatal cardiovascular and metabolic condition 
that has been described in both pediatric and adult 
patients sedated with propofol. Although many reports 
on PRIS have been published since 1992［1］, the 
clinical features and pathophysiology of this condition 
remain uncertain［2-5］. Recently, PRIS attracted serious 
concern in Japan and gave impetus to changes in 
pediatric critical care.
 PRIS is characterized by lactic acidosis, rhabdo-
myolysis, and circulatory collapse after several days of 
high-dose propofol infusion. The patients are typically 
young and critically ill, and the mortality rate is high［6-
13］. However, several studies have also shown cases 
with no change in the lactate level, suggesting that short-
term use/low-dosages of propofol may be safe［14-16］.
 Due to a recent PRIS-related incident in Japan, the 
intermittent or short-term use of propofol in the pediatric 
critical care setting tends to be discouraged. However, 
the avoidance of propofol may deprive sick children of 
the benefits of this useful anesthetic agent.
This study examined the effect of propofol on serum 
lactate, blood gas, and electrolytes in patients admitted 
to the pediatric intensive care unit （PICU） after a long 
surgical procedure during which propofol was used as 
an anesthetic agent.
Ⅱ．Patients and Methods
 Thirty consecutive pediatric patients （2 to 10 years 
old） admitted to the PICU at the Tokyo Metropolitan 
Children’s Medical Center （TMCMC） between April 
2013 and March 2014 for elective neurosurgery using 
a propofol infusion as an anesthetic and those with an 
arterial line in place were enrolled. Congenital metabolic 
diseases and hemodynamic instability during surgery 
were the exclusion criteria but applied to none of the 
patients.
 After admission to the PICU, the arterial lines 
were kept in place, and arterial blood gas samples 
were drawn from the lines in accordance with the 
usual clinical practice including the time of admission 
in all the children. The blood gas analysis including 
lactate and electrolytes was done using ABL 800 Flex 
（Radiometer）.
 The serum lactate level, blood gas analysis including 
the pH, base excess, bicarbonate, and electrolytes 
were assessed. The total dosage and average speed of 
infusion of propofol during surgery were calculated 
and compared between the normal biochemical group 
（lactate＝＜2, potassium＝＜4.5, pH＞＝7.36, base 
excess＞＝－2, bicarbonate＞＝22） and abnormal 
biochemical group （lactate＞2, potassium＞4.5, pH＜
7.36, base excess＜－2, bicarbonate＜22）. Student’s 
T-test was done, and p＜0.05 was defined as statistically 
significant.
 This study was approved by the ethics board of the 
Medical Research Committee of Tokyo Metropolitan 
Children’s Medical Center （TMCMC）. Publication 
was approved by the Institutional Review Board of 
TMCMC. 
Ⅲ．Results
 Thirty cases were enrolled,  and 94  blood 
samples were drawn from the arterial lines. The case 
characteristics are shown in Table 1. The total dosage of 
propofol administered during surgery was 53.8 （37.4-
71.1） mg/kg. The average speed of propofol infusion 
during surgery was 9.9 （8.6-11.9） mg/kg/hr. No case of 
PRIS or mortality occurred.
 The serum lactate and potassium levels were normal 
in all the patients （median serum lactate level: 0.7 （0.6-
1.1） mmol/L, potassium: 3.6 （3.4-3.9））. The blood gas 
speed of infusion. More data are required to establish the safety parameters for propofol administration 
and guidelines for propofol use in Japanese children.
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pH remained normal in most samples （93%） （Table 
2）. The base excess and bicarbonate were in the low 
range （＜－2, ＜22 mmol/L, respectively） in 41% of 
the samples, but there was no statistically significant 
difference in the total dose or average speed of propofol 
infusion. However, the bicarbonate level related to 
the higher average infusion speed of propofol was 
significantly low （Table 3, 4）.
Ⅳ．Discussion
 The use of propofol as a sedative for artificial 
ventilation for children in the intensive care unit （ICU） 
was prohibited in Japan when it was determined that 
indications for the use of the agent were not backed by 
sufficiently robust scientific evidence （despite intra-
operative use in children being allowed）. There are 
several standards and / or clinical guidelines of propofol 
use for children in PICUs outside Japan［17-19］.
 A maximum mean rate of 4 mg/kg/hr and maximum 
duration of 24 hours （total dosage around 100 mg/
kg） are the standard limitations on propofol infusions 
for children in the PICU［15,16］. A recent report by 
the Ministry of Health, Labour and Welfare of Japan 
recommended a maximum rate of 4 mg/kg/hr and 
maximum duration of 48 hours with close blood 
examination and monitoring［20］.
 In the medical treatment of children, drugs are 
used outside the boundaries of approved licensing, for 
example under the terms of off-label use. However, 
this requires critical reasoning and experience with the 
drug involved. Our observational study revealed that a 
maximum mean rate of 9.9 mg/kg/hr and total dosage 
of 53.8 mg/kg did not induce PRIS or death, did not 
elevate the serum lactate nor potassium levels, and 
slightly decreased blood gas pH, while the base excess 
was unaffected by propofol dosage/speed of infusion.
This study has several limitations including the small 
number of cases and samples （30 cases, 94 samples）, 
the fact that it was a single-center study, homogeneity 
of the subjects （those with only postneurosurgical 
procedures）, retrospective model, etc. However, this is 
the only study to reveal the biochemical characteristics 
of children after a propofol infusion.
 Propofol is used worldwide intravenously to induce 
and maintain anesthesia in procedural and critical care 
sedation for children［21-24］. Continuous infusion for 
sedation in the PICU is controversial due to the risk 
of PRIS; however, complete prohibition of its use is 
uncommon. With strict monitoring of, and limits on, its 
use, continuous infusion is allowed in several countries. 
Intermittent use of propofol is usual practice and not a 
Table 1　Characteristics of the cases
Cases （N） 30
Samples （n） 94
Age （months） 80.5（30.25-121）
Hight （cm） 117（85.8-138.5）
Body weight （kg） 21.6（11.4-37.6）
Total dosage （mg/kg） 53.8（37.4-71.1）
Average speed （mg/kg/hr） 9.9（8.6-11.9）
Table 2　 Change in pH after propofol administration during 
surgery
pH ≥7.36 ＜7.36 p
Samples （n） 87 7
Total dosage
（mg/kg）
32.2
（11.2-53.6）
40.4
（5.0-70.0）
0.72 
Average speed
（mg/kg/hr）
9.8
（8.1-12.7）
8.4
（5.2-15.5）
0.30 
Table 3　 Change in bicarbonate after propofol administration 
during surgery
BE ≥－2 ＜－2 p
Samples（n） 55 39
Total dosage
（mg/kg）
36.6
（14.5-54.7）
23.6
（5.4-55.1）
0.31
Average speed
（mg/kg/hr）
9.4
（8.1-11.7）
9.8
（7.8-16.2）
0.38
Table 4　 Change in base excess after propofol administration 
during surgery
HCO3- ≥22 ＜22 p
Samples（n） 55 39
Total dosage
（mg/kg）
34.8
（11.1-52.3）
30.4
（11.8-57.8）
0.60 
Average speed
（mg/kg/hr）
9.0
（7.9-10.9）
10.8
（8.4-14.5）
0.04 
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cause of concern.
 Due to the public outcry caused by the PRIS-related 
incident in Japan, many physicians and institutions have 
become reluctant to use propofol even intermittently 
or for procedural sedation in the critical care and 
emergency department settings. However, such a 
practice may deprive sick children of the benefits of this 
anesthetic agent. More data are needed to establish the 
safety range for propofol administration and guidelines 
for propofol use in Japanese children.
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